Cargando…

SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases

The purpose of this manuscript is to review the effects of sodium-glucose cotransport protein 2 inhibitors (SGLT2is) in patients with chronic kidney disease according to basic mechanisms, current recommendations, and future perspectives. Based on growing evidence from randomized, controlled trials,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Costanzo, Assunta, Esposito, Giovanni, Indolfi, Ciro, Spaccarotella, Carmen Anna Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218404/ https://www.ncbi.nlm.nih.gov/pubmed/37240080 http://dx.doi.org/10.3390/ijms24108732

Ejemplares similares

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy
por: Spaccarotella, Carmen, et al.
Publicado: (2023)

The Outbreak of COVID-19 in Italy: Fighting the Pandemic
por: Indolfi, Ciro, et al.
Publicado: (2020)

Assessment of Non-Invasive Measurements of Oxygen Saturation and Heart Rate with an Apple Smartwatch: Comparison with a Standard Pulse Oximeter
por: Spaccarotella, Carmen, et al.
Publicado: (2022)

Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal
por: Spaccarotella, Carmen, et al.
Publicado: (2021)

SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
por: Kanduri, Swetha R., et al.
Publicado: (2020)

The five-year outcome of the transcatheter aortic valve replacement in the partner 2A study in patients with intermediate surgical risk—what is clear and what it is unclear
por: Spaccarotella, Carmen, et al.
Publicado: (2020)

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
por: De Nicola, Luca, et al.
Publicado: (2022)

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
por: Chen, Xiutian, et al.
Publicado: (2023)

Antioxidant Roles of SGLT2 Inhibitors in the Kidney
por: Llorens-Cebrià, Carmen, et al.
Publicado: (2022)

Old unsolved problems: when and how to treat silent ischaemia
por: Indolfi, Ciro, et al.
Publicado: (2020)

Revascularization and Left Ventricular Dysfunction for ICD Eligibility
por: Romano, Letizia Rosa, et al.
Publicado: (2023)

SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
por: Podestà, Manuel Alfredo, et al.
Publicado: (2023)

Late-Onset Ictal Asystole and Falls Related to Severe Coronary Artery Stenosis: A Case Report
por: Fortunato, Francesco, et al.
Publicado: (2022)

Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions
por: Polimeni, Alberto, et al.
Publicado: (2015)

Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis—Management of Aortic Stenosis with TAVIApp
por: Indolfi, Ciro, et al.
Publicado: (2017)

Migration of a stent from left main and its retrieval from femoral artery: A case report
por: Yasuda, Masakazu, et al.
Publicado: (2017)

The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: results of the SYNTAX II study
por: Indolfi, Ciro, et al.
Publicado: (2019)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
por: Condello, Francesco, et al.
Publicado: (2023)

Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis
por: Li, Ning, et al.
Publicado: (2021)

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease
por: Crimi, Gabriele, et al.
Publicado: (2022)

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
por: Bailey, Clifford J., et al.
Publicado: (2022)

SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
por: Skrabic, Roko, et al.
Publicado: (2022)

Non-invasive myocardial work is reduced during transient acute coronary occlusion
por: Sabatino, Jolanda, et al.
Publicado: (2020)

Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work
por: Sabatino, Jolanda, et al.
Publicado: (2021)

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
por: Paolisso, Pasquale, et al.
Publicado: (2023)

SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
por: Wheeler, David C., et al.
Publicado: (2020)

Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
por: Mende, Christian W.
Publicado: (2021)

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis
por: Polimeni, Alberto, et al.
Publicado: (2020)

Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation
por: Spaccarotella, Carmen, et al.
Publicado: (2020)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
por: Frąk, Weronika, et al.
Publicado: (2023)

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?
por: Voorrips, Suzanne N., et al.
Publicado: (2022)

SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review
por: Kansara, Abhishek, et al.
Publicado: (2022)

Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021)

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
por: Cefalo, Chiara Maria Assunta, et al.
Publicado: (2019)

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
por: Gronda, Edoardo G., et al.
Publicado: (2022)

Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
por: Polimeni, Alberto, et al.
Publicado: (2021)

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
por: Kawanami, Daiji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r5rebh3u9jaqht3i0ghvurcfnp